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Abstract
Background: Desflurane during early reperfusion has been shown to postcondition human myocardium, in vitro.
We investigated the role of adenosine and bradykinin receptors, and generation of radical oxygen species in
desflurane-induced postconditioning in human myocardium.
Methods: We recorded isometric contraction of human right atrial trabeculae hanged in an oxygenated Tyrode’s
solution (34 degrees Celsius, stimulation frequency 1 Hz). After a 30-min hypoxic period, desflurane 6% was
administered during the first 5 min of reoxygenation. Desflurane was administered alone or with pretreatment of
N-mercaptopropionylglycine, a reactive oxygen species scavenger, 8-(p-Sulfophenyl)theophylline, an adenosine
receptor antagonist, HOE140, a selective B2 bradykinin receptor antagonist. In separate groups, adenosine
and bradykinin were administered during the first minutes of reoxygenation alone or in presence of N-
mercaptopropionylglycine. The force of contraction of trabeculae was recorded continuously. Developed force at
the end of a 60-min reoxygenation period was compared (mean ± standard deviation) between the groups by a
variance analysis and post hoc test.
Results: Desflurane 6% (84 ± 6% of baseline) enhanced the recovery of force after 60-min of reoxygenation as
compared to control group (51 ± 8% of baseline, P < 0.0001). N-mercaptopropionylglycine (54 ± 3% of baseline),
8-(p-Sulfophenyl)theophylline (62 ± 9% of baseline), HOE140 (58 ± 6% of baseline) abolished desflurane-induced
postconditioning. Adenosine (80 ± 9% of baseline) and bradykinin (83 ± 4% of baseline) induced postconditioning
(P < 0.0001 vs control), N-mercaptopropionylglycine abolished the beneficial effects of adenosine and bradykinin
(54 ± 8 and 58 ± 5% of baseline, respectively).
Conclusions: In vitro, desflurane-induced postconditioning depends on reactive oxygen species production,
activation of adenosine and bradykinin B2 receptors. And, the cardioprotective effect of adenosine and bradykinin
administered at the beginning of reoxygenation, was mediated, at least in part, through ROS production.
Background
Anesthetic-induced postconditioning (PostC) is a phe-
nomenon whereby a brief exposure of the myocardium
to a volatile halogenated anesthetic, at the very onset of
reperfusion, markedly reduces myocardial injury follow-
ing prolonged ischemia: anesthetic-induced PostC has
been confirmed in several mammalian species including
rat, mouse, rabbit, and human [1-8].
The mechanism of volatile anesthetic-induced
decrease of reperfusion injury remains incompletely
understood. Endogenous activation of opioids, bradyki-
nin, and adenosine receptors can trigger the complex
protective signalling pathway of ischemic PostC [9]. It
has been shown that adenosine and bradykinin postcon-
ditioned isolated rabbit [10] and rat hearts [11], via sti-
mulation of adenosine and B2 receptors. At present, the
involvement of adenosine and bradykinin receptors in
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these receptors were shown to be involved in anes-
thetic-induced preconditioning [12]. On the other hand,
several studies showed that volatile anesthetic triggered
intracellular reactive oxygen species (ROS) production
[13], and that ROS production may mediate and/or trig-
ger the preconditioning signalling cascade. Thus, sevo-
flurane and desflurane-induced preconditioning were
abolished by ROS scavengers [14]. However, only two
studies suggested that ROS were involved in isoflurane-
induced PostC in mouse myocardium in vivo [3], and in
sevoflurane-induced PostC in isolated rat hearts [8].
The objectives of our study were to determine
whether: 1) ROS generation, and adenosine and bradyki-
nin receptor stimulation may be involved in desflurane-
induced PostC, 2) adenosine and bradykinin given at the
beginning of reoxygenation mimic PostC, 3) adenosine
and bradykinin receptors’ activation was followed by
myocardial PostC via ROS production.
Methods
After the approval of local medical ethics committee
(Comité de Protection des Personnes Nord Ouest III,
Caen, France) and written informed consent, right atrial
appendages were obtained during cannulation for cardi-
opulmonary bypass from patients scheduled for routine
coronary artery bypass surgery or aortic valve replace-
ment. All patients received total intravenous anesthesia
with propofol, remifentanil, and pancuronium. Patients
with chronic atrial arrhythmia and with diabetes melli-
tus treated with insulin or oral hypoglycemic agents
were excluded from the study [7,14].
Experimental conditions
Right atrial trabeculae (one or two per appendage) were
dissected and suspended vertically between an isometric
force transducer (MLT0202, ADInstruments, Sydney,
Australia) and a stationary stainless clip in a 200 ml
organ bath filled with daily prepared Tyrode’s modified
solution containing (mM) 120 NaCl, 3.5 KCl, 1.1 MgCl2,
1.8 NaH2PO4, 25.7 NaHCO3, 2.0 CaCl2, and 5.5 glucose.
The organ bath was maintained at 34°C by a thermo-
static water circulator (Polystat micropros, Bioblock, Ill-
kirch, France). The bathing solution was insufflated with
carbogen (95% O2-5% CO2), resulting in a pH of 7.40
and a partial pressure of oxygen of 600 mm Hg. Isolated
muscles were field-stimulated at 1 Hz by two platinum
electrodes with rectangular wave pulses of 5 ms dura-
tion 20% above threshold (CMS 95107, Bionic Instru-
ment, Paris, France).
Trabeculae were equilibrated for 60 to 90 min to allow
stabilization of their optimal mechanical performance at
the apex of the length-active isometric tension curve
(Lmax). At the end of the stabilization period, trabeculae
were randomized to experimental groups detailed below.
The force developed was measured continuously, digi-
tized at a sampling frequency of 400 Hz, and stored on
a Writable Compact Disc for analysis (MacLab, AD
Instrument, Sydney, Australia).
At the end of each experiment, the length and the
weight of the muscle were measured. The muscle cross-
sectional area was calculated from its weight and length
assuming a cylindrical shape and a density of 1. To
avoid core hypoxia, trabeculae included in the study
should have a cross-sectional area less than 1.0 mm
2,a
force of contraction normalized per cross-sectionnal
area (FoC) > 5.0 mN/mm
2 and a ratio of resting force/
total force less than 0.45.
Experimental protocol
In all groups, hypoxia-reoxygenation was performed by
replacing 95% O2-5% CO2 with 95% N2-5% CO2 in the
buffer for 30-min, followed by a 60-min oxygenated
recovery period.
In the Control group (Control; n = 8) muscles were
exposed to the hypoxia-reoxygenation protocol alone. In
the desflurane treatment groups, desflurane was delivered
to the organ bath by the gas flow passing through a speci-
fic calibrated vaporizer. Desflurane concentration in the
carrier gas phase was measured with an infrared cali-
brated analyzer (Capnomac, Datex, Helsinki, Finland).
Desflurane was administered at 6% (Desflurane 6%; n =
6) during the first 5 min of reoxygenation (fig. 1).
Mechanisms involved in desflurane-induced PostC
were studied in presence of desflurane 6%, because we
have previously shown that 6% was effective to induce
PostC in human myocardium, in vitro.
7 In separate
groups exposed to 6% desflurane during the first 5-min
of reoxygenation in the presence of 150 μM N-mercap-
topropionylglycine, a ROS scavenger (Des + MPG; n =
6), 100 μM 8-(p-Sulfophenyl)theophylline, an adenosine
receptor antagonist (Des + SPT; n = 6), 20 nM
HOE140, a selective B2 bradykinin receptor antagonist
(Des + HOE; n = 6). Pharmacological agents were admi-
nistered 5 min before, throughout, and 10 min after des-
flurane administration (fig. 1).
The effect of MPG, SPT, and HOE140 alone was
studied in separate groups exposed to 150 μMN -
mercaptopropionylglycine (MPG; n = 6), 100 μM8 -
(p-Sulfophenyl)theophylline (SPT; n = 6), 20 nM
HOE140 (HOE; n = 6), 5 min before and during the
first 15 min of reoxygenation (fig. 1).
Sequence of activation of adenosine and bradykinin
receptors and ROS generation
In separate experimental groups, trabeculae were ran-
domly assigned to receive 1) 100 μMa d e n o s i n ea l o n e ,
in the 15 first min of reoxygenation (adenosine (ADO)
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(5 min before and 15 min after reoxygenation) with 100
μM SPT (ADO + SPT; n = 6), or 3) with 150 μMM P G
(ADO + MPG; n = 6) (fig. 1).
In 3 other separate experimental groups, trabeculae
were randomly assigned to receive: 1) 1 μMb r a d y k i n i n
alone, in the 15 first min of reoxygenation (BK group;
n = 6), or 2) co-superfused with pre-treatment (5 min
before and 15 min after reoxygenation) with 20 nM
HOE140 (BK + HOE; n = 6), or 3) with 150 μMM P G
(BK + MPG; n = 6) (fig. 1).
The concentrations of inhibitors MPG [14], SPT [10],
HOE 140 [11], and activators adenosine [10], bradykinin
[15] used here have been validated in previous experi-
mental studies, in vitro.
Chemicals
MPG and adenosine were purchased from Calbiochem
(VWR International, Fontenay sous Bois, France) and
bradykinin, HOE 140, SPT were obtained from Sigma
Aldrich (Saint Quentin Fallavier, France). Desflurane
was purchased from GlaxoWellcome (Marly-le-Roi,
France).
Statistical Analysis
The endpoint of the study was the recovery of FoC at
60 min of reoxygenation (FoC60, expressed as percent of
baseline). All values were compared by ANOVA with
application of a post hoc Bonferroni test. Power analysis
calculated a group size of n = 5 to detect a difference of
40% in FoC (Control and inhibitors group: FoC60 =5 0
Figure 1 Schematic diagram depicting the experimental protocol. In the Desflurane + inhibitor groups and Inhibitor groups, MPG was
administered at 150 μM, SPT was administered at 100 μM, and HOE 140 was administered at 20 nM. In adenosine and adenosine + inhibitor
groups, adenosine was administered at 100 μM. In bradykinin and bradykinin + inhibitor groups, bradykinin was administered at 1 μM. MPG: N-
mercaptopropionylglycine; SPT: 8-(p-Sulfophenyl) théophylline.
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9% of baseline) with a power of 0.8 at alpha-level of 0.05.
The number of experiments per group was calculated
based on an one-way analysis of variance (ANOVA) with
4 Control and inhibitors groups and 1 desflurane 6%
group. Data are expressed as mean ± SD. Baseline values
of main mechanical parameters, age, preoperative left ven-
tricular ejection fraction, and FoC60 were compared by
univariate analysis of variance with group factor as the
independent variable. If the P value was less than 0.05, a
Bonferroni post hoc analysis was performed. Within-group
data were analyzed over time using two way analysis of
variance for repeated measures and Bonferroni post hoc
analysis with group factor and time (baseline, hypoxia 5,
10, 20, 30 min, and reoxygenation 5, 10, 20, 30, 40, 50, and
60 min) as independent variables.
Results
There were no differences between groups for patients’
demographic data, preoperative treatments, and left ven-
tricular ejection fraction (Table 1). Eighty six human
right atrial trabeculae were studied. There were no dif-
ferences in baseline values for Lmax,c r o s s - s e c t i o n n a l
area, ratio of resting force to total force, and FoC
between groups (Table 2).
Effects of desflurane on hypoxia reoxygenation on
human atrial trabeculae
In the Control group, reoxygenation resulted in a partial
recovery of FoC (FoC60: 51 ± 8% of baseline). Desflurane
increased the FoC60 as compared to Control group (FoC60:
84 ± 6% of baseline vs. Control; P < 0.0001) (fig. 2).
Effects of N-mercaptopropionylglycine, 8-(p-Sulfophenyl)
theophylline and HOE 140 in desflurane treated
preparations
Desflurane-induced enhanced recovery of FoC at the end
of reoxygenation was abolished (P < 0.0001) in presence
of MPG (FoC60: 54 ± 3% of baseline), SPT (FoC60:6 2±
9% of baseline), HOE 140 (FoC60: 58 ± 6% of baseline).
As compared to the control group (control: 51 ± 8%
of baseline), MPG alone (MPG: 56 ± 2% of baseline;
Table 1 Patients demographic data, preoperative drug treatments, and preoperative left ventricular ejection fraction
Groups and heart disease Age (Yr) Preoperative drug treatments LVEF(%)
Control
AVR (n = 2); CABG (n = 6)
66 ± 7 ACE (3), bAB (5), BZD (1), CA (0), COR (0), FUR (1), MOL (0), STA (5), NT (0) 73 ± 11
Desflurane
AVR (n = 1); CABG (n = 5)
67 ± 9 ACE (2), bAB (5), BZD (0), CA (1), COR (0), FUR (0), MOL (1), STA (4), NT (0) 64 ± 19
Des + MPG
AVR (n = 3); CABG (n = 3)
64 ± 12 ACE (2), bAB (3), BZD (1), CA (1), COR (0), FUR (0), MOL (0), STA (1), NT (0) 71 ± 21
Des + SPT
AVR (n = 4); CABG (n = 2)
66 ± 21 ACE (3), bAB (3), BZD (2), CA (0), COR (0), FUR (0), MOL (1), STA (1), NT (0) 67 ± 10
Des + HOE
AVR (n = 2); CABG (n = 4)
69 ± 8 ACE (4), bAB (5), BZD (2), CA (0), COR (0), FUR (0), MOL (3), STA (4), NT (2) 59 ± 2
ADO
AVR (n = 1); CABG (n = 5)
70 ± 8 ACE (2), bAB (2), BZD (0), CA (1), COR (0), FUR (0), MOL (0), STA (4), NT (0) 65 ± 10
ADO + SPT
AVR (n = 3); CABG (n = 3)
55 ± 11 ACE (4), bAB (4), BZD (1), CA (2), COR (0), FUR (1), MOL (0), STA (2), NT (0) 60 ± 12
ADO + MPG
AVR (n = 2); CABG (n = 4)
73 ± 9 ACE (3), bAB (2), BZD (3), CA (0), COR (0), FUR (0), MOL (0), STA (3), NT (0) 73 ± 6
BK
AVR (n = 5); CABG (n = 1)
67 ± 11 ACE (3), bAB (3), BZD (2), CA (2), COR (0), FUR (0), MOL (0), STA (6), NT (0) 59 ± 15
BK + HOE
AVR (n = 4); CABG (n = 2)
60 ± 15 ACE (4), bAB (4), BZD (1), CA (2), COR (0), FUR (2), MOL (0), STA (3), NT (1) 65 ± 16
BK + MPG
AVR (n = 3); CABG (n = 3)
66 ± 17 ACE (2), bAB (1), BZD (2), CA (0), COR (0), FUR (1), MOL (0), STA (3), NT (0) 61 ± 9
MPG
AVR (n = 5); CABG (n = 1)
71 ± 2 ACE (4), bAB (2), BZD (2), CA (0), COR (0), FUR (0), MOL (0), STA (5), NT (0) 71 ± 9
SPT
AVR (n = 5); CABG (n = 1)
68 ± 15 ACE (2), bAB (2), BZD (0), CA (0), COR (0), FUR (2), MOL (0), STA (2), TNT (0) 74 ± 8
HOE
AVR (n = 0); CABG (n = 6)
66 ± 10 ACE (5), bAB (4), BZD (2), CA (2) COR (0), FUR (0), MOL (2), STA (4), NT (3) 70 ± 9
The number in brackets after heart disease and drug abbreviation indicate the number of patients. Age and LVEF are expressed as mean ± SD.
ACE: angiotensin-converting enzyme inhibitors; ADO: adenosine; AVR: aortic valve replacement; bAB: b-adrenergic blocking drugs; BK: bradykinin; BZD:
benzodiazepine; CA: calcium channel antagonists; CABG: coronary artery bypass graft; COR: amiodarone; Des: desflurane; FUR: furosemide; HOE: HOE 140; LVEF:
preoperative left ventricular ejection fraction; MOL: molsidomine; MPG: N-mercaptopropionylglycine; NT: nitroglycerin; SPT: 8-(p-Sulfophenyl) théophylline; STA:
statins.
Data are mean ± SD.
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0.06), and HOE 140 alone (HOE 140: 54 ± 7% of base-
line; P = 0.29) did not significantly modify FoC60 (fig. 2).
Effects of adenosine and bradykinin on hypoxia
reoxygenation
Administration of adenosine and bradykinin, during the
first 15 min of the reoxygenation period, significantly
increased the recovery of FoC60 as compared to the con-
trol group (80 ± 9% of baseline in adenosine group and
83 ± 4% of baseline in bradykinin group; vs. Control
group, P < 0.0001). Recovery of FoC60 measured in pre-
sence of adenosine or bradykinin were similar to that
measured in Desflurane group (respectively P =0 . 3 7
and P = 0.74 vs. desflurane group) (fig. 3).
Effects of 8-(p-Sulfophenyl)theophylline and N-
mercaptopropionylglycine on adenosine administration
The effect of adenosine on FoC60 was abolished by pre-
treatment with SPT (FoC60: 53 ± 8% of baseline), and
with MPG (FoC60: 54 ± 8% of baseline) (P < 0.0001 vs.
adenosine group) (fig. 3).
Effects of HOE 140 and N-mercaptopropionylglycine on
bradykinin administration
The enhanced recovery of FoC60 induced by bradykinin
was abolished by the pre-treatment with HOE140 (48 ±
8% of baseline), and with MPG (55 ± 3% of baseline)
(P < 0.0001 vs. bradykinin group) (fig. 3).
Discussion
In the present study, we showed that the cardioprotec-
tion triggered by desflurane during early reoxygenation
involved ROS generation, and stimulation of adenosine
and bradykinin B2 receptors. Furthermore, adenosine
and bradykinin-induced PostC involved at least in part,
ROS production.
The present study shows that administration of MPG
abolished desflurane-induced PostC in human myocar-
dium, in vitro. These results strongly suggest that desflur-
ane-induced PostC involved ROS production. At present,
only two studies have shown, in mouse and rat heart,
that isoflurane and sevoflurane-induced PostC was abol-
ished by treatment with ROS scavengers [3,8]. In con-
trast, numerous studies have shown that ROS play a
fundamental role in anesthetic-induced preconditioning
[14,16]. Müllenheim et al. demonstrated that ROS sca-
vengers, blocked the reduction in myocardial infarct size
resulting from isoflurane-induced preconditioning [16].
Isoflurane-induced preconditioning was mediated by
ROS generated from electron transport chain complex
III, in rabbit heart [17]. Moreover, in ventricular myo-
cytes volatile anesthetics inhibit complex I of the electron
transport chain [18], and, ROS mediated the mitochon-
drial uncoupling induced by desflurane treatment [19].
Tanaka et al. reported that mitochondrial adenosine tri-
phosphate-sensitive potassium (mitoKATP) channel open-
ing triggered isoflurane-induced preconditioning via ROS
generation, in rabbit in vivo [20]. We have previously
shown that opening of mitoKATP was an essential step of
desflurane-induced PostC in human myocardium [7].
Thus, it could be hypothesized that desflurane-induced
PostC generates ROS via mitoKATP channels opening.
Further studies are required to examine the exact rela-
tionship between mitoKATP channel opening and ROS
generation during early reperfusion.
Table 2 Control values of main mechanical parameters of human right atrial trabeculae
Experimental Groups Lmax (mm) CSA (mm
2) FoC
(mN.mm
-2)
RF/TF
Control (n = 8) 6.8 ± 0.6 0.49 ± 0.10 24 ± 4 0.33 ± 0.03
Desflurane (n = 6) 6.5 ± 0.7 0.56 ± 0.07 25 ± 3 0.30 ± 0.04
Des + MPG (n = 6) 7.5 ± 0.6 0.56 ± 0.03 23 ± 5 0.27 ± 0.04
Des + SPT (n = 6) 6.0 ± 0.6 0.54 ± 0.06 23 ± 3 0.28 ± 0.02
Des + HOE (n = 6) 5.8 ± 0.4 0.46 ± 0.04 25 ± 3 0.34 ± 0.04
ADO (n = 6) 7.7 ± 0.8 0.59 ± 0.07 27 ± 2 0.28 ± 0.03
ADO + SPT (n = 6) 6.1 ± 0.4 0.60 ± 0.05 25 ± 3 0.24 ± 0.02
ADO + MPG (n = 6) 6.8 ± 0.9 0.44 ± 0.09 22 ± 4 0.40 ± 0.04
BK (n = 6) 5.8 ± 0.5 0.39 ± 0.06 28 ± 4 0.31 ± 0.04
BK + HOE (n = 6) 5.1 ± 0.4 0.54 ± 0.07 22 ± 2 0.29 ± 0.05
BK + MPG (n = 6) 6.0 ± 0.4 0.40 ± 0.04 23 ± 2 0.31 ± 0.03
MPG (n = 6) 6.3 ± 0.7 0.47 ± 0.11 30 ± 1 0.33 ± 0.06
SPT (n = 6) 6.6 ± 0.5 0.54 ± 0.06 26 ± 3 0.29 ± 0.03
HOE (n = 6) 5.3 ± 0.53 0.40 ± 0.05 26 ± 4 0.34 ± 0.04
Lmax: maximal length at the apex of the length-active force curve; CSA: cross sectionnal area; FoC: Force of contraction normalized per cross sectionnal area; RF/
TF: ratio of resting force on total force. Data are mean ± SD.
ADO: adenosine, BK: bradykinin, Des: desflurane, HOE: HOE 140, MPG: N-mercaptopropionylglycine, SPT: 8-(p-Sulfophenyl) théophylline.
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mulation in desflurane-induced PostC was studied here
for the first time using human myocardium. The present
results show that both adenosine and B2 bradykinin
receptors’ stimulation are involved in desflurane-induced
PostC. Pre-treatment with adenosine receptors inhibitor
(SPT) and specific B2 bradykinin receptor’ inhibitor
(HOE140) abolished desflurane-induced PostC. Simi-
larly, the beneficial effects of ischemic PostC were abol-
ished by SPT, in rat and rabbit hearts [10,21,22]. Penna
et al. showed that HOE 140 infusion eliminated the car-
dioprotective effect induced by ischemic PostC, in iso-
lated rat hearts [11]. Additionally, a growing body of
evidence supports the concept that anesthetic PostC
triggers a cardioprotective cascade of molecular signal-
ling events similar to that of ischemic PostC [23]. Then,
previous studies showed specific involvement of A2A
and A3 adenosine receptors in ischemic PostC in mouse
[10,24], and A1,A 2B adenosine receptors in rabbit heart,
in vitro [25,26]. Using gene knockout mice, it has been
shown that ischemic PostC-induced decreased in infarct
volume was triggered by activation of adenosine A1 and
bradykinin B2 receptors [27]. In contrast, with anes-
thetic-induced PostC, the involvement of adenosine
receptors (specifically the A1 adenosine receptors) sti-
mulation in isoflurane-induced preconditioning has been
established [28-30].
Then, we showed that activation of adenosine and
bradykinin receptors (via administration of adenosine or
bradykinin), at the onset of reoxygenation, enhanced the
recovery of FoC60 as compared to the control group. Lu
et al, in rat ventricular myocytes, showed that adeno-
sine-induced PostC was mediated by stimulation of ade-
nosine A1 receptors as suggested by abolition of
cardioprotective effect of adenosine in presence of 1,3-
dipropyl-8-cyclopentylxanthine (DPCPX) as A1 adeno-
sine receptor antagonist [31]. Nevertheless, Penna et al.
showed that a 3-min administration of adenosine at the
beginning of reperfusion did not decrease infarct volume
in isolated rat hearts [21]. This discrepancy may result
from differences in adenosine concentration between
studies (i.e. 30 μMi nP e n n a ’s study vs 100 μMi nL u ’s
Figure 2 Recovery of force of contraction of isolated human
right atrial trabeculae at the end of the 60-min reoxygenation
period after the 30-min hypoxic challenge in groups exposed
to Desflurane 6% (Des) alone or in the presence of MPG, SPT,
HOE. Data are mean ± SD. *P < 0.0001 vs. control, Des + MPG, Des
+ SPT, Des + HOE, MPG, SPT, HOE. Des: desflurane; HOE: HOE 140;
MPG: N-mercaptopropionylglycine; SPT: 8-(p-Sulfophenyl)
théophylline.
Figure 3 Recovery of force of contraction of isolated human
right atrial trabeculae at the end of the 60-min reoxygenation
period after the 30-min hypoxic challenge in groups exposed
to Desflurane 6% (Des) alone, exposed to adenosine (ADO)
alone or in presence of SPT, MPG; exposed to bradykinin (BK)
alone or in presence of HOE, MPG. Control and Des groups are
the same that presented in figure 2. Data are mean ± SD. *P <
0.0001 vs. control, ADO + SPT, ADO + MPG, BK + HOE, BK + MPG.
ADO: adenosine, BK: bradykinin; Des: desflurane; HOE: HOE 140;
MPG: N-mercaptopropionylglycine; SPT: 8-(p-Sulfophenyl)
théophylline.
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which may be ineffective to stimulate adenosine recep-
t o r s .T h u s ,P e n n aet al showed that a 40 min adminis-
tration of adenosine during reperfusion was necessary to
decrease infarct size [21]. In another study, Penna et al
have shown, in isolated rat hearts, that brief repetitive
administration of bradykinin during early reperfusion
could trigger PostC, whereas continuous administration
in the same period wasn’t cardioprotective [11].
Our data showed that pretreatment by HOE 140 abol-
ished bradykinin effects, suggesting that bradykinin
effects at the beginning of reoxygenation were mediated
by the specific stimulation of B2 receptors, in accor-
dance with Penna’ s data [11]. Although the exact
mechanism by which adenosine and bradykinin protect
human myocardium in vitro is still unknown, studies
based on animal models have suggested that ROS may
mediate PostC [11]. Our data show that MPG abolished
adenosine- and bradykinin-induced postC, suggesting
that adenosine and bradykinin receptors’ activation trig-
gered PostC, at least in part, via ROS generation during
early reoxygenation. In addition to ROS production, it
has been shown that activation of adenosine and brady-
kinin receptors during reperfusion may promote mito-
KATP channels opening [11,31], activation of the RISK
pathway including pro survival PI3K/Akt and MEK/ERK
1/2 pathways, p70s6K activation [15,32,33], and phos-
phorylation of GSK-3b, and prevent the mPTP opening,
in rat ventricular myocytes and in isolated rat heart
[34,35] These signalling steps have been shown to be
involved in ischemic and anesthetic induced PostC.
Nevertheless, one study showed that preconditioning
triggered by adenosine did not include ROS signaling in
isolated rabbit heart [36].
Finally, enhanced recovery of force of human atrial
trabeculae after exposure to desflurane, adenosine and
bradykinin may suggest an anti-stunning effect of PostC.
Whereas PostC reduced infarct size, it does not protect
against myocardial stunning in dogs and rabbits [37],
moreover post-ischemic systolic function was not mod-
ify by ischemic PostC and adenosine as compared to
control group in isolated rat heart [21]. Definitely, our
results cannot be extrapolated to myocardial stunning
which is defined as a completely reversible myocardial
dysfunction, because in the present experimental model
the contractile dysfunction was not reversible even after
2 hours of reoxygenation [38].
Several limitations must be considered when interpret-
ing our results. First the effects of anesthetic drugs, dis-
eases, or medical treatments received by the patients
before obtaining atrial appendages cannot be ruled out.
Furthermore, although our experimental groups showed
comparable demographic data (table 1), age has been
shown to impair ischemic PostC in senescent mouse
hearts [39-41], and should also be considered in
patients. Second, our experiments were performed
under moderate hypothermia (34°C) to ensure stability
of trabeculae over time. However, during surgical proce-
dures moderate hypothermia may occur. Third, block-
ade of adenosine receptors with SPT was not isoform
specific, and we have investigated the role of ROS pro-
duction using MPG. We did not directly measure ROS
production nor the particular species of ROS. Fourth, as
described in myocardial preconditioning, the beneficial
effects of PostC have also been described on reperfu-
sion-induced arrhythmias [42] and myocardial conctrac-
tility [43]. Fifth, we measured recovery of post hypoxic
contractile function but not the infarct volume. How-
ever, it is not possible to precisely quantify the volume
of necrosis in isolated trabeculae. Furthermore, it has
been shown that the improved recovery of contractile
function produced by preconditioning was proportional
to reduced infarct size [44]. Finally, previous studies
from our laboratories clearly showed that contractile
dysfunction is a reliable parameter.
Conclusion
We have shown that stimulation of adenosine and bra-
dykinin B2 receptors and ROS generation, during early
reoxygenation, were involved in desflurane-induced
PostC in human myocardium, in vitro. Additionally, the
cardioprotective effect of adenosine and bradykinin
administered at the beginning of reoxygenation, was
mediated, at least in part, through ROS production.
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